This site uses cookies to provide you with a more responsive and personalised service. By using this site you agree to our use of cookies. Please read our cookie notice for more information on the cookies we use and how to delete or block them.

Bookmark Print page

Healthcare & Life Sciences

Our Healthcare and Life Sciences team led by David L Jones provides a dedicated corporate finance advisory service, with an excellent track record of success driven by strong industry knowledge.

Our team works closely with corporates, management teams, individuals and private equity houses on buy-side and sell-side transactions, as well as JVs and public sector partnerships. The team provides a full range of financial advisory services to sub-industries including healthcare services, consumer healthcare, pharmaceuticals, biotechnology, and medical devices.

Having a global network of Healthcare and Life Science professionals allows Deloitte to operate at the forefront of the industry and maintain strong relationships with financial investors on a global scale.

We have been commended for the achievements, innovation and ground breaking work completed across the healthcare arena and the team was named Healthcare Corporate Financier of the year in 2013 by HealthInvestor.

Thought pieces

  • Working differently to provide early diagnosis
    A UK Deloitte Centre for Health Solutions report which examines how healthcare commissioners and providers can work differently with the diagnostic industry and other providers to increase early diagnosis.
  • Impact of European Austerity on Pharmaceutical policy and pricing
    A UK Deloitte Centre for Health solutions report that looks to understand the current European pharmaceutical market, the mechanisms for reducing pharmaceutical spending, the future of the pharmaceutical landscape, and the actions the pharmaceutical industry needs to take to survive current austerity.
  • Measuring the return from Pharmaceutical innovation 2012
    This Deloitte report is the third in an annual series exploring the pharmaceutical industry’s performance in generating a return from its investment in new product innovation.
  • Telecare and Telehealth
    'Telecare and Telehealth - A game changer for health and social care’ looks at the role that telecare and telehealth can play in helping to transform health and social care by enabling commissioners and providers to respond effectively to rising demand for health and social care services.
  • Primary Care: Today and tomorrow
    A new report from the Deloitte Centre for Health Solutions examines the capacity and capability of general practice now and in the future, with a focus on GPs and general practice nurses. The report highlights the need for general practice to work differently to cope effectively with the increasing demands it faces. This will be especially pertinent as GPs take on the role of commissioners of local healthcare services.

Related links

Find out more about Deloitte's Healthcare & Life Sciences offering in the UK.

Key contact

  • David L Jones
    Partner
    +44 (0)20 7007 2259
  • Vivienne Howell
    Assistant Director
    +44 (0)20 7007 1585

Share this page

Email this Send to LinkedIn Send to Facebook Tweet this More sharing options
Follow:

Get in touch

More on Deloitte